Wenlin Shao
- Hematology top 1%
- Acute Myeloid Leukemia Research 4
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress 3
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 6
- Histone Deacetylase Inhibitors Research 4
- Genetics top 10%
- Estrogen and related hormone effects 3
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 3
-
- Prostate Cancer Treatment and Research 4
- Co-authors
- László NagyRichard J. LinRonald M. EvansWilliam R. SellersRaymond PagliariniWilson H. MillerClara NerviWilliam W. Lamph
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Wenlin Shao
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Hematology 694
- Biochemistry 185
- Molecular Biology 1.7k
- Genetics 294
- Oncology 280
Countries citing papers authored by Wenlin Shao
This map shows the geographic impact of Wenlin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlin Shao more than expected).
Fields of papers citing papers by Wenlin Shao
This network shows the impact of papers produced by Wenlin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlin Shao. The network helps show where Wenlin Shao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenlin Shao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2021 | 13 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 20 | |
| 8 | 2018 | 7 | |
| 9 | 2015 | 147 | |
| 10 | 2015 | 179 | |
| 11 | 2013 | 57 | |
| 12 | Potent anticancer activity of the pan-deacetylase inhibitor panobinostat (LBH589) as a single agent in in vitro and in vivo tumor models | 2008 | 15 |
| 13 | Potent anticancer activity of the deacetylase inhibitor panobinostat (LBH589) in colon cancer cell lines and patient-derived primary colon cancer xenografts | 2008 | 2 |
| 14 | 2007 | 3 | |
| 15 | 2002 | 14 | |
| 16 | 2001 | 10 | |
| 17 | 2000 | 20 | |
| 18 | Role of the histone deacetylase complex in acute promyelocytic leukaemiabreakdown → | 1998 | 920 |
| 19 | 1998 | 303 | |
| 20 | 1997 | 143 |
About Wenlin Shao
Wenlin Shao is a scholar working on Biochemistry, Hematology, Oncology, Pulmonary and Respiratory Medicine and Physiology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (6 papers), Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Estrogen and related hormone effects (3 papers), PARP inhibition in cancer therapy (3 papers) and Antioxidant Activity and Oxidative Stress (3 papers). The work is most often cited by research in Hematology (694 citations), Biochemistry (185 citations), Molecular Biology (1.7k citations), Genetics (294 citations) and Oncology (280 citations). Wenlin Shao has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include László Nagy, Richard J. Lin, Ronald M. Evans, William R. Sellers, Raymond Pagliarini, Wilson H. Miller, Clara Nervi, William W. Lamph, Laura Benedetti and Angelika Rosenauer. Their work appears in journals such as Cancer Research, Blood, Clinical Cancer Research, Journal of Clinical Oncology and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.